FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Molcho, L
   Ben-Zur, T
   Barhum, Y
   Offen, D
AF Molcho, Lior
   Ben-Zur, Tali
   Barhum, Yael
   Offen, Daniel
TI DJ-1 based peptide, ND-13, promote functional recovery in mouse model of
   focal ischemic injury
SO PLOS ONE
LA English
DT Article
ID AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; OXIDATIVE
   STRESS; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; GLUTAMATE NEUROTOXICITY;
   STROKE REHABILITATION; MOTOR RECOVERY; NEURONAL DEATH; CELL-DEATH
AB Stroke is a leading cause of death worldwide and inflicts serious long-term damage and disability. The vasoconstrictor Endothelin-1, presenting long-term neurological deficits associated with excitotoxicity and oxidative stress is being increasingly used to induce focal ischemic injury as a model of stroke. A DJ-1 based peptide named ND-13 was shown to protect against glutamate toxicity, neurotoxic insults and oxidative stress in various animal models. Here we focus on the benefits of treatment with ND-13 on the functional outcome of focal ischemic injury. Wild type C57BL/6 mice treated with ND-13, after ischemic induction in this model, showed significant improvement in motor function, including improved body balance and motor coordination, and decreased motor asymmetry. We found that DJ-1 knockout mice are more sensitive to Endothelin-1 ischemic insult than wild type mice, contributing thereby additional evidence to the widely reported relevance of DJ-1 in neuroprotection. Furthermore, treatment of DJ-1 knockout mice with ND-13, following Endothelin-1 induced ischemia, resulted in significant improvement in motor functions, suggesting that ND-13 provides compensation for DJ-1 deficits. These preliminary results demonstrate a possible basis for clinical application of the ND-13 peptide to enhance neuroprotection in stroke patients.
C1 [Molcho, Lior; Offen, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.
   [Ben-Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel.
RP Offen, D (reprint author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Offen, D (reprint author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel.
EM danioffen@gmail.com
FU UGH Pharma, Inc. [ND-13]
FX UGH Pharma, Inc. supplied the peptide (ND-13) used in the studies. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alberts B, 2002, MOL BIOL CELL, P1
   Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104
   BEEM KM, 1974, J BIOL CHEM, V249, P7298
   Brooks SP, 2011, NEUROMETHODS, V61, P65, DOI 10.1007/978-1-61779-298-4_5
   Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002
   Chao NJ, 2014, CURR MED CHEM, V21, P2043, DOI 10.2174/0929867321666131228204533
   Chehaibi K, 2016, J STROKE CEREBROVASC
   CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171
   COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908
   Cuzzocrea S, 2001, PHARMACOL REV, V53, P135
   Deng P, 2011, J CEREBR BLOOD F MET, V31, P1823, DOI 10.1038/jcbfm.2011.88
   Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0
   Doeppner TR, 2010, EXP NEUROL, V223, P548, DOI 10.1016/j.expneurol.2010.02.001
   Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7
   Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884
   FUXE K, 1989, ACTA PHYSIOL SCAND, V137, P155, DOI 10.1111/j.1748-1716.1989.tb08733.x
   Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112
   Glat MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148170
   Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007
   Gou X, 2010, TAT NEP1 40 NOVEL TH
   Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469
   Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107
   HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29
   Horie N, 2008, J NEUROSCI METH, V173, P286, DOI 10.1016/j.jneumeth.2008.06.013
   Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200
   Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x
   Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003
   Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104
   Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48
   KUROSAWA M, 1991, J CARDIOVASC PHARM, V17, pS340, DOI 10.1097/00005344-199100177-00097
   Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97
   Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5
   Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549
   Lipton P, 1999, PHYSIOL REV, V79, P1431
   Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   MELLORS A, 1966, J BIOL CHEM, V241, P4353
   MELLORS A, 1966, LIPIDS, V1, P282, DOI 10.1007/BF02531617
   Milani P, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/836760
   Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007
   Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nguemeni C, 2015, J NEUROSCI METH, V242, P72, DOI 10.1016/j.jneumeth.2015.01.005
   O'Dell MW, 2009, ANNU REV MED, V60, P55, DOI 10.1146/annurev.med.60.042707.104248
   Pantcheva P, 2014, NEURAL REGEN RES, V9, P1430, DOI 10.4103/1673-5374.139458
   Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1
   Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001
   Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8
   Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200
   Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7
   Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t
   Singh P, 2003, MOL CELL BIOCHEM, V243, P139, DOI 10.1023/A:1021668314070
   Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104
   Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192
   Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647
   van der Merwe C, 2015, EUR J NEUROSCI, V41, P1113, DOI 10.1111/ejn.12872
   Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012
   Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x
   Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477
   Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153
   WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682
   WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267
   Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408
   Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985
   Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553
NR 70
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2018
VL 13
IS 2
AR e0192954
DI 10.1371/journal.pone.0192954
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7ND
UT WOS:000426276000048
PM 29489843
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Murata, H
   Takamatsu, H
   Lie, SL
   Kataoka, K
   Huh, NH
   Sakaguchi, M
AF Murata, Hitoshi
   Takamatsu, Hitoshi
   Lie, Sulai
   Kataoka, Ken
   Huh, Nam-ho
   Sakaguchi, Masakiyo
TI NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions
SO PLOS ONE
LA English
DT Article
ID TRANSCRIPTION FACTOR NRF2; GENE; MUTATIONS; PROMOTES; PROTEIN;
   NEUROPROTECTION; DETOXIFICATION; PARKINSONISM; MITOCHONDRIA; PROTECTION
AB Mutations of the PTEN-induced putative kinase 1 (PINK1) gene are a cause of autosomal recessive forms of Parkinson's disease. Recent studies have revealed that PINK1 is an essential factor for controlling mitochondrial quality, and that it protects cells from oxidative stresses. Although there has been considerable progress in the elucidation of various aspects of PINK1 protein regulation such as activation, stability and degradation, the transcriptional regulation of PINK1 mRNA under stress conditions remains unclear. In this study, we found that nuclear factor (erythroid-derived 2)-like 2 (NRF2), an antioxidant transcription factor, regulates PINK1 expression under oxidative stress conditions. Damaged mitochondria arising from stress conditions induced NRF2-dependent transcription of the PINK1 gene through production of reactive oxygen species (ROS). Either an ROS scavenger or forced expression of KEAP1, a potent inhibitory partner to NRF2, restricted PINK1 expression induced by activated NRF2. Transcriptionally up-regulated PINK1 diminished oxidative stress-associated cell death. The results indicate that PINK1 expression is positively regulated by NRF2 and that the NRF2-PINK1 signaling axis is deeply involved in cell survival.
C1 [Murata, Hitoshi; Takamatsu, Hitoshi; Lie, Sulai; Huh, Nam-ho; Sakaguchi, Masakiyo] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan.
   [Kataoka, Ken] Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan.
RP Sakaguchi, M (reprint author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM masa-s@md.okayama-u.ac.jp
RI Sakaguchi, Masakiyo/B-2280-2011; MURATA, Hitoshi/B-2327-2011
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [25860216]; Okayama Medical Foundation
FX Funding: Funding was provided by The Ministry of Education, Culture,
   Sports, Science, and Technology of Japan (25860216); The Okayama Medical
   Foundation.
CR Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Arena G, 2013, CELL DEATH DIFFER
   Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619
   Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102
   Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82
   Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501
   De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189
   Dinkova-Kostova AT, 2008, PLANTA MED, V74, P1548, DOI 10.1055/s-2008-1081296
   Gomez-Sanchez R, 2014, NEUROBIOL DIS, V62, P426, DOI 10.1016/j.nbd.2013.10.021
   Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113
   Jin Y, 2012, ONCOL REP, V27, P695, DOI 10.3892/or.2011.1543
   Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x
   Kensler T W, 2000, Drug Metabol Drug Interact, V17, P3
   Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027
   Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   McMahon M, 2001, CANCER RES, V61, P3299
   Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106
   Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x
   Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016
   Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390
   Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754
   Priyadarshini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081851
   Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798
   Ryu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071178
   Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016
   Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Wu ZH, 2013, GENE DEV, V27, P157, DOI 10.1101/gad.203406.112
NR 42
TC 26
Z9 27
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 10
PY 2015
VL 10
IS 11
AR e0142438
DI 10.1371/journal.pone.0142438
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV7CT
UT WOS:000364430700104
PM 26555609
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Kubli, DA
   Cortez, MQ
   Moyzis, AG
   Najor, RH
   Lee, Y
   Gustafsson, AB
AF Kubli, Dieter A.
   Cortez, Melissa Q.
   Moyzis, Alexandra G.
   Najor, Rita H.
   Lee, Youngil
   Gustafsson, Asa B.
TI PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and
   Activation of Mitophagy in Cardiac Myocytes
SO PLOS ONE
LA English
DT Article
ID CELL-DEATH; PINK1/PARKIN-MEDIATED MITOPHAGY; DAMAGED MITOCHONDRIA;
   MITOFUSIN 2; AUTOPHAGY; BNIP3; UBIQUITIN; PROTEIN; DYSFUNCTION;
   INDUCTION
AB Myocyte function and survival relies on the maintenance of a healthy population of mitochondria. The PINK1/Parkin pathway plays an important role in clearing defective mitochondria via autophagy in cells. However, how the PINK1/Parkin pathway regulates mitochondrial quality control and whether it coordinates with other mitophagy pathways are still unclear. Therefore, the objective of this study was to investigate the effect of PINK1-deficiency on mitochondrial quality control in myocytes. Using PINK1-deficient ( PINK1-/-) mice, we found that Parkin is recruited to damaged cardiac mitochondria in hearts after treatment with the mitochondrial uncoupler FCCP or after a myocardial infarction even in the absence of PINK1. Parkin recruitment to depolarized mitochondria correlates with increased ubiquitination of mitochondrial proteins and activation of mitophagy in PINK1-/-myocytes. In addition, induction of mitophagy by the atypical BH3-only protein BNIP3 is unaffected by lack of PINK1. Overall, these data suggest that Parkin recruitment to depolarized cardiac mitochondria and subsequent activation of mitophagy is independent of PINK1. Moreover, alternative mechanisms of Parkin activation and pathways of mitophagy remain functional in PINK1-/-myocytes and could compensate for the PINK1 deficiency.
C1 [Kubli, Dieter A.; Cortez, Melissa Q.; Moyzis, Alexandra G.; Najor, Rita H.; Lee, Youngil; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
RP Gustafsson, AB (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
EM asag@ucsd.edu
FU U.S. Public Health Service [HL087023, HL101217, HL085577]; American
   Heart Association Established Investigator Award [14EIA18970095]
FX This work was supported in part by U.S. Public Health Service Grants
   HL087023, HL101217, HL085577, and an American Heart Association
   Established Investigator Award 14EIA18970095.
CR Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416
   Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09
   Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x
   Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Hammerling BC, 2014, J MOL CELL CARDIOL, V75, P122, DOI 10.1016/j.yjmcc.2014.07.013
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736
   Kitada T, 1998, NATURE, V392, P605
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16
   Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Zheng XD, 2014, EMBO J, V33, P1621, DOI 10.15252/embj.201489185
NR 43
TC 28
Z9 29
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 25
PY 2015
VL 10
IS 6
AR e0130707
DI 10.1371/journal.pone.0130707
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL4OY
UT WOS:000356933800075
PM 26110811
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Patel, AS
   Song, JW
   Chu, SG
   Mizumura, K
   Osorio, JC
   Shi, Y
   El-Chemaly, S
   Lee, CG
   Rosas, IO
   Elias, JA
   Choi, AMK
   Morse, D
AF Patel, Avignat S.
   Song, Jin Woo
   Chu, Sarah G.
   Mizumura, Kenji
   Osorio, Juan C.
   Shi, Ying
   El-Chemaly, Souheil
   Lee, Chun Geun
   Rosas, Ivan O.
   Elias, Jack A.
   Choi, Augustine M. K.
   Morse, Danielle
TI Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by
   Transforming Growth Factor-Beta1 in Pulmonary Fibrosis
SO PLOS ONE
LA English
DT Article
ID PINK1-DEFICIENT MICE; DAMAGED MITOCHONDRIA; MITOPHAGY; PARKIN; PROMOTES;
   DEGRADATION; ACTIVATION; AUTOPHAGY; DISEASES; RECRUITMENT
AB Background
   Epithelial cell death is a major contributor to fibrogenesis in the lung. In this study, we sought to determine the function of mitochondria and their clearance (mitophagy) in alveolar epithelial cell death and fibrosis.
   Methods
   We studied markers of mitochondrial injury and the mitophagy marker, PTEN-induced putative kinase 1 (PINK1), in IPF lung tissues by Western blotting, transmission electron microscopy (TEM), and immunofluorescence. In vitro experiments were carried out in lung epithelial cells stimulated with transforming growth factor-beta 1 (TGF-beta 1). Changes in cell function were measured by Western blotting, flow cytometry and immunofluorescence. In vivo experiments were performed using the murine bleomycin model of lung fibrosis.
   Results
   Evaluation of IPF lung tissue demonstrated increased PINK1 expression by Western blotting and immunofluorescence and increased numbers of damaged mitochondria by TEM. In lung epithelial cells, TGF-beta 1 induced mitochondrial depolarization, mitochondrial ROS, and PINK1 expression; all were abrogated by mitochondrial ROS scavenging. Finally, Pink1(-/-) mice were more susceptible than control mice to bleomycin induced lung fibrosis.
   Conclusion
   TGF-beta 1 induces lung epithelial cell mitochondrial ROS and depolarization and stabilizes the key mitophagy initiating protein, PINK1. PINK1 ameliorates epithelial cell death and may be necessary to limit fibrogenesis.
C1 [Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA.
   [Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Harvard Univ, Sch Med, Boston, MA USA.
   [Song, Jin Woo] Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Lee, Chun Geun] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA.
   [Rosas, Ivan O.] Lovelace Resp Res Inst, Pulm Fibrosis Program, Albuquerque, NM USA.
   [Elias, Jack A.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.
   [Mizumura, Kenji; Choi, Augustine M. K.] Weill Cornell Med Coll, Dept Med, New York, NY USA.
RP Song, JW (reprint author), Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea.
EM jwsong@amc.seoul.kr
OI Osorio, Juan C/0000-0001-8090-1551; Lee, Chun Geun/0000-0002-9514-3658
FU NIH [R01HL087122-01, P01HL114501]; Basic Science Research Program
   through the National Research Foundation of Korea (NRF) - Ministry of
   Education [NRF-2013R1A1A1064957]; Asan Institute for Life Sciences, Asan
   Medical Center, Seoul, Korea [14-495]
FX D.M. was supported by NIH Grant R01HL087122-01. JWS was supported by
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Education
   (NRF-2013R1A1A1064957) and by a grant (14-495) from the Asan Institute
   for Life Sciences, Asan Medical Center, Seoul, Korea. I. O.R. and
   A.M.K.C were supported by NIH Grant P01HL114501. The funders had no
   roles in study design, data colelction and analysis, decision to
   publish, or preparation of the manuscript.
CR Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012
   Baker TA, 2014, PHYSIOL RES, V63, P311
   Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119
   Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942
   Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005
   Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008
   Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kitada T, 1998, NATURE, V392, P605
   Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x
   Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081
   Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/bse0470099, 10.1042/BSE0470099]
   Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394
   Pociask DA, 2004, LAB INVEST, V84, P1013, DOI 10.1038/labinvest.3700109
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208
   Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211
   Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455
   Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC
   Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 40
TC 54
Z9 57
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2015
VL 10
IS 3
AR e0121246
DI 10.1371/journal.pone.0121246
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BN
UT WOS:000352138500206
PM 25785991
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Duong, T
   Kim, J
   Ruley, HE
   Jo, D
AF Duong, Tam
   Kim, Jaetaek
   Ruley, H. Earl
   Jo, Daewoong
TI Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated
   Phenotypes in Cultured Cells and Animals
SO PLOS ONE
LA English
DT Article
ID PROTECTS DOPAMINERGIC-NEURONS; UBIQUITIN LIGASE ACTIVITY; NUCLEAR IMPORT
   INHIBITOR; MOUSE MODEL; ANTITUMOR-ACTIVITY; MOLECULAR-MECHANISMS;
   INDUCED TOXICITY; ALPHA-SYNUCLEIN; L-DOPA; DELIVERY
AB Parkinson's disease (PD) is a neurodegenerative disorder of complex etiology characterized by the selective loss of dopaminergic neurons, particularly in the substantia nigra. Parkin, a tightly regulated E3 ubiquitin ligase, promotes the survival of dopaminergic neurons in both PD and Parkinsonian syndromes induced by acute exposures to neurotoxic agents. The present study assessed the potential of cell-permeable parkin (CP-Parkin) as a neuroprotective agent. Cellular uptake and tissue penetration of recombinant, enzymatically active parkin was markedly enhanced by the addition of a hydrophobic macromolecule transduction domain (MTD). The resulting CP-Parkin proteins (HPM13 and PM10) suppressed dopaminergic neuronal toxicity in cells and mice exposed to 6-hydroxydopamine (6-OHDH) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). These included enhanced survival and dopamine expression in cultured CATH. a and SH-SY5Y neuronal cells; and protection against MPTP-induced damage in mice, notably preservation of tyrosine hydroxylase-positive cells with enhanced dopamine expression in the striatum and midbrain, and preservation of gross motor function. These results demonstrate that CP-Parkin proteins can compensate for intrinsic limitations in the parkin response and provide a therapeutic strategy to augment parkin activity in vivo.
C1 [Duong, Tam; Jo, Daewoong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea.
   [Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 156756, South Korea.
   [Ruley, H. Earl] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Jo, Daewoong] ProCell Therapeut Inc, ProCell R&D Inst, Seoul, South Korea.
RP Jo, D (reprint author), Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA.
EM dae-woong.jo@vanderbilt.edu
FU Ministry of Education, Science and Technology, Republic of Korea
   [KRF-2006-331-E00102]
FX This work was supported by a grant of the Rising Professor Support
   Program (KRF-2006-331-E00102 to D.J.) of Ministry of Education, Science
   and Technology, Republic of Korea. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation ofthe manuscript.
CR Ahn EH, 2013, FREE RADICAL BIO MED, V55, P36, DOI 10.1016/j.freeradbiomed.2012.11.008
   Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204
   Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891
   DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191
   Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093
   Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011
   Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x
   Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200
   Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X
   Jeong HJ, 2012, MOL CELLS, V33, P471, DOI 10.1007/s10059-012-2255-8
   Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180
   Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269
   Joshi RL, 2011, FEBS LETT, V585, P1573, DOI 10.1016/j.febslet.2011.05.006
   Kim DW, 2010, FREE RADICAL BIO MED, V48, P969, DOI 10.1016/j.freeradbiomed.2010.01.023
   Kim MJ, 2012, BIOCHIMIE, V94, P2448, DOI 10.1016/j.biochi.2012.07.005
   Kim MJ, 2010, J NEUROL SCI, V298, P64, DOI 10.1016/j.jns.2010.08.016
   Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107
   Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080
   Lee YP, 2012, FEBS J, V279, P1929, DOI 10.1111/j.1742-4658.2012.08574.x
   Lim J, 2013, BIOMATERIALS, V34, P6261, DOI 10.1016/j.biomaterials.2013.05.011
   Lim J, 2013, CLIN CANCER RES, V19, P680, DOI 10.1158/1078-0432.CCR-12-2692
   Lim J, 2012, MOL THER, V20, P1540, DOI 10.1038/mt.2012.102
   Lim J, 2011, CANCER RES, V71, P7216, DOI 10.1158/0008-5472.CAN-11-2015
   Lipski J, 2011, PROG NEUROBIOL, V94, P389, DOI 10.1016/j.pneurobio.2011.06.005
   Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18
   Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200
   Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200
   Liu XY, 2000, J BIOL CHEM, V275, P16774
   Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093
   Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101
   Luthra PM, 2009, J NEUROSCI METH, V178, P284, DOI 10.1016/j.jneumeth.2008.12.019
   Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440
   Masserano JM, 1996, MOL PHARMACOL, V50, P1309
   Moore DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013235
   Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X
   Ramamoorthy A, 2007, BIOCHEMISTRY-US, V46, P965, DOI 10.1021/bi061895g
   Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200
   Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012
   Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9
   Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
   Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290
   Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316
   Trempe JF, 2013, SCIENCE
   Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623
   Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200
   Walden H, 2012, CELL MOL LIFE SCI, V69, P3053, DOI 10.1007/s00018-012-0978-5
   Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200
   Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0
NR 53
TC 2
Z9 3
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2014
VL 9
IS 7
AR e102517
DI 10.1371/journal.pone.0102517
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1PC
UT WOS:000339618600089
PM 25019626
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Damiano, M
   Gautier, CA
   Bulteau, AL
   Ferrando-Miguel, R
   Gouarne, C
   Paoli, MG
   Pruss, R
   Auchere, F
   L'Hermitte-Stead, C
   Bouillaud, F
   Brice, A
   Corti, O
   Lombes, A
AF Damiano, Maria
   Gautier, Clement A.
   Bulteau, Anne-Laure
   Ferrando-Miguel, Rosa
   Gouarne, Caroline
   Paoli, Marc Giraudon
   Pruss, Rebecca
   Auchere, Francoise
   L'Hermitte-Stead, Caroline
   Bouillaud, Frederic
   Brice, Alexis
   Corti, Olga
   Lombes, Anne
TI Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice
SO PLOS ONE
LA English
DT Article
ID COMPLEX I DEFICIENCY; OXIDATIVE STRESS; ENERGY-METABOLISM; SYNAPTIC
   FUNCTION; YEAST MODEL; MOUSE MODEL; DISEASE; PINK1; DYSFUNCTION;
   MUTATIONS
AB Loss of Parkin, encoded by PARK2 gene, is a major cause of autosomal recessive Parkinson's disease. In Drosophila and mammalian cell models Parkin has been shown in to play a role in various processes essential to maintenance of mitochondrial quality, including mitochondrial dynamics, biogenesis and degradation. However, the relevance of altered mitochondrial quality control mechanisms to neuronal survival in vivo is still under debate. We addressed this issue in the brain of PARK2(-/-) mice using an integrated mitochondrial evaluation, including analysis of respiration by polarography or by fluorescence, respiratory complexes activity by spectrophotometric assays, mitochondrial membrane potential by rhodamine 123 fluorescence, mitochondrial DNA content by real time PCR, and oxidative stress by total glutathione measurement, proteasome activity, SOD2 expression and proteins oxidative damage. Respiration rates were lowered in PARK2(-/-) brain with high resolution but not standard respirometry. This defect was specific to the striatum, where it was prominent in neurons but less severe in astrocytes. It was present in primary embryonic cells and did not worsen in vivo from 9 to 24 months of age. It was not associated with any respiratory complex defect, including complex I. Mitochondrial inner membrane potential in PARK2(-/-) mice was similar to that of wild-type mice but showed increased sensitivity to uncoupling with ageing in striatum. The presence of oxidative stress was suggested in the striatum by increased mitochondrial glutathione content and oxidative adducts but normal proteasome activity showed efficient compensation. SOD2 expression was increased only in the striatum of PARK2(-/-) mice at 24 months of age. Altogether our results show a tissue-specific mitochondrial defect, present early in life of PARK2(-/-) mice, mildly affecting respiration, without prominent impact on mitochondrial membrane potential, whose underlying mechanisms remain to be elucidated, as complex I defect and prominent oxidative damage were ruled out.
C1 [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Hop La Pitie Salpetriere, CRICM, INSERM, U975, Paris, France.
   [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Univ Paris 06, UMR S975, Paris, France.
   [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] CNRS, UMR 7225, Paris, France.
   [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Inst Cochin, Inserm U1016, Paris, France.
   [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] CNRS, UMR 8104, Paris, France.
   [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Univ Paris 05, UMR S1016, Paris, France.
   [Gouarne, Caroline; Paoli, Marc Giraudon; Pruss, Rebecca] Trophos SA, Marseille, France.
   [Auchere, Francoise] Univ Paris Diderot CNRS, Inst Jacques Monod, Dept Pathol Mol & Cellulaire, Lab Mitochondries Met & Stress Oxydatif, Paris, France.
   [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France.
RP Lombes, A (reprint author), Inst Cochin, Inserm U1016, Paris, France.
EM anne.lombes@inserm.fr
RI Corti, Olga/I-4981-2016; Bouillaud, Frederic/L-3238-2017; Lombes,
   Anne/G-4684-2014
OI Corti, Olga/0000-0003-2093-7389; Lombes, Anne/0000-0002-9064-0399;
   Bouillaud, Frederic/0000-0002-7518-9237
FU Institut national de la sante et de la recherche medicale; Association
   France Parkinson; Fondation de France; Agence Nationale de la Recherche;
   MEFOPA - EU 7th Framework Programme [HEALTH-2009-241791]; Fondation ICM,
   "Investissements d'avenir'' [ANR-10-IAIHU-06]; Fondation pour la
   Recherche Medicale
FX This work was supported by Institut national de la sante et de la
   recherche medicale, Association France Parkinson, Fondation de France,
   Agence Nationale de la Recherche, MEFOPA (funded by the EU 7th Framework
   Programme, Grant Agreement HEALTH-2009-241791), Fondation ICM,
   "Investissements d'avenir'' ANR-10-IAIHU-06. CG was supported by a
   fellowship from the Fondation pour la Recherche Medicale. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178
   Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014
   Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101
   Cardoso SM, 2011, CURR PHARM DESIGN, V17, P3390
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinopoulos C, 2011, METHODS MOL BIOL, V793, P311, DOI 10.1007/978-1-61779-328-8_20
   Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002
   Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010
   Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200
   Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629
   FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286
   Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200
   Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016
   Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537
   MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281
   Magistretti PJ, 1996, ANN NY ACAD SCI, V777, P380, DOI 10.1111/j.1749-6632.1996.tb34449.x
   Mann VM, 1992, BRAIN, V115
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   NARENDRA D, 2012, COLD SPRING HARB PER, V4
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102
   Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Schagger H, 2001, J BIOL CHEM, V276, P37861
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531
   Viengchareun S, 2007, ANTIVIR THER, V12, P919
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101
   Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018
   Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
NR 64
TC 20
Z9 20
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 24
PY 2014
VL 9
IS 6
AR e99898
DI 10.1371/journal.pone.0099898
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK7UT
UT WOS:000338633900017
PM 24959870
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Parganlija, D
   Klinkenberg, M
   Dominguez-Bautista, J
   Hetzel, M
   Gispert, S
   Chimi, MA
   Drose, S
   Mai, S
   Brandt, U
   Auburger, G
   Jendrach, M
AF Parganlija, Dajana
   Klinkenberg, Michael
   Dominguez-Bautista, Jorge
   Hetzel, Miriam
   Gispert, Suzana
   Chimi, Marthe A.
   Droese, Stefan
   Mai, Soeren
   Brandt, Ulrich
   Auburger, Georg
   Jendrach, Marina
TI Loss of PINK1 Impairs Stress-Induced Autophagy and Cell Survival
SO PLOS ONE
LA English
DT Article
ID PINK1-ASSOCIATED PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION;
   OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; QUALITY-CONTROL; CANCER CELLS;
   APOPTOSIS; MITOPHAGY; PARK6; VULNERABILITY
AB The mitochondrial kinase PINK1 and the ubiquitin ligase Parkin are participating in quality control after CCCP- or ROS-induced mitochondrial damage, and their dysfunction is associated with the development and progression of Parkinson's disease. Furthermore, PINK1 expression is also induced by starvation indicating an additional role for PINK1 in stress response. Therefore, the effects of PINK1 deficiency on the autophago-lysosomal pathway during stress were investigated. Under trophic deprivation SH-SY5Y cells with stable PINK1 knockdown showed downregulation of key autophagic genes, including Beclin, LC3 and LAMP-2. In good agreement, protein levels of LC3-II and LAMP-2 but not of LAMP-1 were reduced in different cell model systems with PINK1 knockdown or knockout after addition of different stressors. This downregulation of autophagic factors caused increased apoptosis, which could be rescued by overexpression of LC3 or PINK1. Taken together, the PINK1-mediated reduction of autophagic key factors during stress resulted in increased cell death, thus defining an additional pathway that could contribute to the progression of Parkinson's disease in patients with PINK1 mutations.
C1 [Parganlija, Dajana; Klinkenberg, Michael; Dominguez-Bautista, Jorge; Hetzel, Miriam; Gispert, Suzana; Auburger, Georg; Jendrach, Marina] Goethe Univ Frankfurt, Sch Med, Dept Neurol, D-60054 Frankfurt, Germany.
   [Chimi, Marthe A.; Droese, Stefan; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60054 Frankfurt, Germany.
   [Mai, Soeren] Goethe Univ Frankfurt, Ctr Excellence Frankfurt Macromol Complexes, Inst Cell Biol & Neurosci, Kinemat Cell Res Grp, D-60054 Frankfurt, Germany.
   [Droese, Stefan] Goethe Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.
RP Jendrach, M (reprint author), Goethe Univ Frankfurt, Sch Med, Dept Neurol, D-60054 Frankfurt, Germany.
EM jendrach@bio.uni-frankfurt.de
RI Drose, Stefan/E-4903-2010; CEF, MC/B-4919-2018; Brandt,
   Ulrich/C-4406-2008
OI Drose, Stefan/0000-0002-9361-9034; Brandt, Ulrich/0000-0003-1869-6811;
   Klinkenberg, Michael/0000-0002-0241-4712
FU German Federal Ministry of Education (BMBF) [01GS08138]; National Genome
   Research Network (NGFNplus); GerontoMitoSys network (BMBF) [PTJ
   0315584A]
FX German Federal Ministry of Education (BMBF 01GS08138), National Genome
   Research Network (NGFNplus), GerontoMitoSys network (BMBF PTJ 0315584A).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622
   Ahmed I, 2012, J NEUROSCI, V32, P16503, DOI 10.1523/JNEUROSCI.0209-12.2012
   Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038
   Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneuro1.2010.198
   Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21
   Berthier A, 2011, HUM PATHOL, V42, P75, DOI 10.1016/j.humpath.2010.05.016
   Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x
   Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475
   Cui T, 2011, BRAIN RES, V1394, P1, DOI 10.1016/j.brainres.2011.01.035
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007
   Jendrach M, 2009, J BIOENERG BIOMEMBR, V41, P481, DOI 10.1007/s10863-009-9256-0
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016
   Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8
   Klinkenberg M, 2010, NEUROSCIENCE, V166, P422, DOI 10.1016/j.neuroscience.2009.12.068
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lenzi P, 2012, ARCH ITAL BIOL, V150, P194, DOI 10.4449/aib.v150i2/3.1417
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106
   Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200
   Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051
   Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249
   SPIELMANN H, 1981, ANAL BIOCHEM, V113, P172, DOI 10.1016/0003-2697(81)90061-0
   Strecker V, 2010, MECH AGEING DEV, V131, P48, DOI 10.1016/j.mad.2009.11.005
   Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007
   Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455
   Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 50
TC 20
Z9 21
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2014
VL 9
IS 4
AR e95288
DI 10.1371/journal.pone.0095288
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG2DX
UT WOS:000335227400049
PM 24751806
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sanchez, G
   Varaschin, RK
   Bueler, H
   Marcogliese, PC
   Park, DS
   Trudeau, LE
AF Sanchez, Gonzalo
   Varaschin, Rafael K.
   Bueeler, Hansruedi
   Marcogliese, Paul C.
   Park, David S.
   Trudeau, Louis-Eric
TI Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout,
   Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; NEURONAL VULNERABILITY; DJ-1-DEFICIENT MICE;
   SYNAPTIC PLASTICITY; DISEASE; DEFICITS; BEHAVIOR; NEUROTRANSMISSION;
   COMPENSATION; INACTIVATION
AB Parkinson's disease (PD) is one of the most prevalent neurodegenerative brain diseases; it is accompanied by extensive loss of dopamine (DA) neurons of the substantia nigra that project to the putamen, leading to impaired motor functions. Several genes have been associated with hereditary forms of the disease and transgenic mice have been developed by a number of groups to produce animal models of PD and to explore the basic functions of these genes. Surprisingly, most of the various mouse lines generated such as Parkin KO, Pink1 KO, DJ-1 KO and LRRK2 transgenic have been reported to lack degeneration of nigral DA neuron, one of the hallmarks of PD. However, modest impairments of motor behavior have been reported, suggesting the possibility that the models recapitulate at least some of the early stages of PD, including early dysfunction of DA axon terminals. To further evaluate this possibility, here we provide for the first time a systematic comparison of DA release in four different mouse lines, examined at a young age range, prior to potential age-dependent compensations. Using fast scan cyclic voltammetry in striatal sections prepared from young, 6-8 weeks old mice, we examined sub-second DA overflow evoked by single pulses and action potential trains. Unexpectedly, none of the models displayed any dysfunction of DA overflow or reuptake. These results, compatible with the lack of DA neuron loss in these models, suggest that molecular dysfunctions caused by the absence or mutation of these individual genes are not sufficient to perturb the function and survival of mouse DA neurons.
C1 [Sanchez, Gonzalo; Varaschin, Rafael K.; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.
   [Sanchez, Gonzalo; Varaschin, Rafael K.; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Neurosci, Montreal, PQ H3C 3J7, Canada.
   [Bueeler, Hansruedi] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.
   [Marcogliese, Paul C.; Park, David S.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.
RP Trudeau, LE (reprint author), Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.
EM louis-eric.trudeau@umontreal.ca
RI Bueler, Hansruedi/J-6965-2017
OI Bueler, Hansruedi/0000-0002-4892-7177; Park, David/0000-0002-4490-3784;
   Trudeau, Louis-Eric/0000-0003-4684-1377; Sanchez,
   Gonzalo/0000-0003-4415-1866; Marcogliese, Paul/0000-0002-8011-7852
FU Michael J. Fox Foundation for Parkinson's Research; Brain Canada
   Foundation; Krembil Foundation; Conselho Nacional de Pesquisa e
   Desenvolvimento (CNPq), Brazil
FX This work was funded by a Rapid Response award from the Michael J. Fox
   Foundation for Parkinson's Research to L.-E. T. as well as by a grant to
   L.-E. T. and D. S. P. from the Brain Canada Foundation and the Krembil
   Foundation. R. K. V. was supported by a Science without Borders
   fellowship from the Conselho Nacional de Pesquisa e Desenvolvimento
   (CNPq), Brazil. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7
   Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038
   Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001
   Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200
   Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041
   Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013
   Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105
   Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25
   Hornykiewicz O, 2008, NEURODEGENER DIS, V5, P114, DOI 10.1159/000113678
   Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239
   Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110
   Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102
   Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104
   Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x
   Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x
   Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010
   Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349
   Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009
   Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014
   Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108
   Martel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020402
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Oyama G, 2010, BRAIN RES, V1352, P214, DOI 10.1016/j.brainres.2010.06.065
   Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/mt.sj.6300067
   Paxinos G, 2005, RAT BRAIN STEREOTAXI
   Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24
   Platt NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036397
   Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109
   Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290
   Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007
   Watson MB, 2012, EXP NEUROL, V237, P318, DOI 10.1016/j.expneurol.2012.06.025
   Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001
NR 51
TC 10
Z9 10
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 14
PY 2014
VL 9
IS 4
AR e94826
DI 10.1371/journal.pone.0094826
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6GP
UT WOS:000336970400117
PM 24733019
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Kuo, SH
   Tang, GM
   Ma, KR
   Babij, R
   Cortes, E
   Vonsattel, JPG
   Faust, PL
   Sulzer, D
   Louis, ED
AF Kuo, Sheng-Han
   Tang, Guomei
   Ma, Karen
   Babij, Rachel
   Cortes, Etty
   Vonsattel, Jean-Paul G.
   Faust, Phyllis L.
   Sulzer, David
   Louis, Elan D.
TI Macroautophagy Abnormality in Essential Tremor
SO PLOS ONE
LA English
DT Article
ID HUNTINGTONS-DISEASE; AUTOPHAGY INDUCTION; MUTANT HUNTINGTIN;
   ALPHA-SYNUCLEIN; PURKINJE-CELLS; BECLIN 1; MICE; NEURODEGENERATION;
   PATHOLOGY; MODELS
AB Macroautophagy is a cellular mechanism for the clearance of protein aggregates and damaged organelles. Impaired macroautophagy has been observed in neurodegenerative disorders. We investigated the macroautophagy pathway in essential tremor (ET) cases compared to age-matched controls. We analyzed microtubule-associated protein light chain 3-II (LC3-II), S6K, phosphorylated S6K, beclin-1, and mitochondrial membrane proteins levels by Western blot in the postmortem cerebellum of 10 ET cases and 11 controls. We also performed immunohistochemistry in 12 ET cases and 13 controls to quantify LC3 clustering in Purkinje cells (PCs). LC3-II protein levels were significantly lower in ET cases vs. controls on Western blot (0.84 +/- 0.14 vs. 1.00 +/- 0.14, p = 0.02), and LC3-II clustering in PCs by immunohistochemistry was significantly lower in ET cases vs. controls (2.03 +/- 3.45 vs. 8.80 +/- 9.81, p = 0.03). In ET cases, disease duration was inversely correlated with LC3-II protein level (r = -0.64, p = 0.046). We found that mitochondrial membrane proteins were accumulated in ET (TIM23: 1.36 +/- 0.11 in ET cases vs. 1.00 +/- 0.08 in controls, p = 0.02; TOMM20: 1.63 +/- 0.87 in ET cases vs. 1.00 +/- 0.14 in controls, p = 0.03). Beclin-1, which is involved in macroautophagy, was strikingly deficient in ET (0.42 +/- 0.13 vs. 1.00 +/- 0.35, p<0.001). Decreased macroautophagy was observed in the ET cerebellum, and this could be due to a decrease in beclin-1 levels, which subsequently lead to mitochondrial accumulation as a result of autophagic failure. This provides a possible means by which perturbed macroautophagy could contribute to PC pathology in ET.
C1 [Kuo, Sheng-Han; Tang, Guomei; Sulzer, David; Louis, Elan D.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA.
   [Ma, Karen; Babij, Rachel; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, GH Sergievsky Ctr, New York, NY USA.
   [Cortes, Etty; Vonsattel, Jean-Paul G.; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA.
   [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA.
   [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] New York Presbyterian Hosp, New York, NY USA.
   [Louis, Elan D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
RP Louis, ED (reprint author), Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA.
EM EDL2@columbia.edu
OI Kuo, Sheng-Han/0000-0002-9412-931X
FU National Institutes of Health (Bethesda, MD) [R01 NS42859]; Udall Center
   for Parkinson's Disease Research (Columbia University); Parkinson's
   Disease Foundation; JPB Foundation; American Academy of Neurology
   Clinical Research Training Fellowship
FX This work was supported by R01 NS42859 from the National Institutes of
   Health (Bethesda, MD), Udall Center for Parkinson's Disease Research
   (Columbia University), Parkinson's Disease Foundation, JPB Foundation,
   and American Academy of Neurology Clinical Research Training Fellowship.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneuro1.2010.198
   Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8
   Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008
   Chakrabarti L, 2009, MOL BRAIN, V29, P24
   Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1
   Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313
   Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010
   Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373
   Erickson-Davis CR, 2010, J NEUROPATH EXP NEUR, V69, P262, DOI 10.1097/NEN.0b013e3181d1ad04
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Higashi S, 2011, J NEUROPATH EXP NEUR, V70, P264, DOI 10.1097/NEN.0b013e318211c86a
   Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kuo SH, 2011, J NEUROL NEUROSUR PS, V82, P1038, DOI 10.1136/jnnp.2010.213330
   Kuo SH, 2011, ACTA NEUROPATHOL, V121, P287, DOI 10.1007/s00401-010-0776-9
   Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008
   Louis ED, 2006, NEUROLOGY, V66, P1756, DOI 10.1212/01.wnl.0000218162.80315.b9
   Louis ED, 2005, MOVEMENT DISORD, V20, P1361, DOI 10.1002/mds.20583
   Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266
   Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838
   Louis ED, 2009, ARCH NEUROL-CHICAGO, V66, P1202, DOI 10.1001/archneurol.2009.217
   Louis ED, 2009, NEUROSCI LETT, V450, P287, DOI 10.1016/j.neulet.2008.11.043
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047
   Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964
   Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585
   Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Sosunov AA, 2008, EPILEPSIA, V49, P53, DOI 10.1111/j.1528-1167.2008.01493.x
   Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009
   Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9
   Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014
   Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928
   Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9
NR 40
TC 3
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 27
PY 2012
VL 7
IS 12
AR e53040
DI 10.1371/journal.pone.0053040
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 061EA
UT WOS:000312829100112
PM 23300858
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Mofarrahi, M
   Sigala, I
   Guo, YT
   Godin, R
   Davis, EC
   Petrof, B
   Sandri, M
   Burelle, Y
   Hussain, SNA
AF Mofarrahi, Mahroo
   Sigala, Ioanna
   Guo, Yeting
   Godin, Richard
   Davis, Elaine C.
   Petrof, Basil
   Sandri, Marco
   Burelle, Yan
   Hussain, Sabah N. A.
TI Autophagy and Skeletal Muscles in Sepsis
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL PERMEABILITY TRANSITION; NF-KAPPA-B; ELECTRON-TRANSPORT
   CHAIN; MULTIPLE ORGAN FAILURE; LEG MUSCLE; IN-VIVO; DYSFUNCTION;
   ACTIVATION; HEART; ENDOTOXEMIA
AB Background: Mitochondrial injury develops in skeletal muscles during the course of severe sepsis. Autophagy is a protein and organelle recycling pathway which functions to degrade or recycle unnecessary, redundant, or inefficient cellular components. No information is available regarding the degree of sepsis-induced mitochondrial injury and autophagy in the ventilatory and locomotor muscles. This study tests the hypotheses that the locomotor muscles are more prone to sepsis-induced mitochondrial injury, depressed biogenesis and autophagy induction compared with the ventilatory muscles.
   Methodology/Principal Findings: Adult male C57/Bl6 mice were injected with i.p. phosphate buffered saline (PBS) or E. coli lipopolysaccharide (LPS, 20 mg/kg) and sacrificed 24 h later. The tibialis anterior (TA), soleus (SOLD) and diaphragm (DIA) muscles were quickly excised and examined for mitochondrial morphological injury, Ca++ retention capacity and biogenesis. Autophagy was detected with electron microscopy, lipidation of Lc3b proteins and by measuring gene expression of several autophagy-related genes. Electron microscopy revealed ultrastructural injuries in the mitochondria of each muscle, however, injuries were more severe in the TA and SOL muscles than they were in the DIA. Gene expressions of nuclear and mitochondrial DNA transcription factors and co-activators (indicators of biogenesis) were significantly depressed in all treated muscles, although to a greater extent in the TA and SOL muscles. Significant autophagosome formation, Lc3b protein lipidation and upregulation of autophagy-related proteins were detected to a greater extent in the TA and SOL muscles and less so in the DIA. Lipidation of Lc3b and the degree of induction of autophagy-related proteins were significantly blunted in mice expressing a muscle-specific I kappa B alpha superrepresor.
   Conclusion/Significance: We conclude that locomotor muscles are more prone to sepsis-induced mitochondrial injury, decreased biogenesis and increased autophagy compared with the ventilatory muscles and that autophagy in skeletal muscles during sepsis is regulated in part through the NF kappa B transcription factor.
C1 [Mofarrahi, Mahroo; Guo, Yeting; Petrof, Basil; Hussain, Sabah N. A.] McGill Univ, Ctr Hlth, Dept Crit Care Med, Montreal, PQ, Canada.
   [Mofarrahi, Mahroo; Guo, Yeting; Petrof, Basil; Hussain, Sabah N. A.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada.
   [Sigala, Ioanna] Univ Athens, Sch Med, Evangelismos Hosp, George P Livanos Lab,Dept Crit Care & Pulm Serv, GR-11527 Athens, Greece.
   [Godin, Richard; Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.
   [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.
   [Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.
RP Hussain, SNA (reprint author), McGill Univ, Ctr Hlth, Dept Crit Care Med, Montreal, PQ, Canada.
EM sabah.hussain@muhc.mcgill.ca
FU Canadian Institute of Health Research (CIHR); Natural Sciences and
   Engineering Council of Canada (NSERC); Fondazione Telethon
FX This work was funded by a grant from the Canadian Institute of Health
   Research (CIHR) awarded to Sabah N. A. Hussain and by grants from the
   Natural Sciences and Engineering Council of Canada (NSERC) awarded to
   Sabah N. A. Hussain and Yan Burelle. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alvarez S, 2004, FREE RADICAL BIO MED, V37, P1472, DOI 10.1016/j.freeradnbiomed.2004.06.034
   Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005
   Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06
   Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC
   Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysioi.01157.2004
   Carreira RS, 2010, AUTOPHAGY, V19, P6
   Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08
   CRIOLLO A, 2009, EMBO J, V29, P619
   DAVIS EC, 1993, LAB INVEST, V68, P89
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152
   Elmore SP, 2001, FASEB J, V15, P2286
   Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006
   Fredriksson K, 2007, CRIT CARE MED, V35, pS449, DOI 10.1097/01.CCM.0000278048.00896.4B
   Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686
   Gellerich FN, 2002, BIOSCIENCE REP, V22, P99, DOI 10.1023/A:1016017224003
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0
   Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099
   Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069
   Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Marcil M, 2006, J MOL CELL CARDIOL, V41, P998, DOI 10.1016/j.yjmcc.2006.08.117
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788
   Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056
   SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433
   Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003
   Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x
   Vanasco V, 2008, FREE RADICAL RES, V42, P815, DOI 10.1080/10715760802438709
   WeltyWolf KE, 1996, SHOCK, V5, P378, DOI 10.1097/00024382-199605000-00011
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
   Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
NR 46
TC 62
Z9 63
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2012
VL 7
IS 10
AR e47265
DI 10.1371/journal.pone.0047265
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 021MR
UT WOS:000309889400067
PM 23056618
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Thomas, KJ
   Jacobson, MR
AF Thomas, Kelly Jean
   Jacobson, Marty R.
TI Defects in Mitochondrial Fission Protein Dynamin-Related Protein 1 Are
   Linked to Apoptotic Resistance and Autophagy in a Lung Cancer Model
SO PLOS ONE
LA English
DT Article
ID CARCINOMA CELL-LINES; MAMMALIAN AUTOPHAGY; DRP1; FUSION; MEMBRANE;
   PHOSPHORYLATION; TUMORIGENICITY; DEGRADATION; MORPHOLOGY; INHIBITION
AB Evasion of apoptosis is implicated in almost all aspects of cancer progression, as well as treatment resistance. In this study, resistance to apoptosis was identified in tumorigenic lung epithelial (A549) cells as a consequence of defects in mitochondrial and autophagic function. Mitochondrial function is determined in part by mitochondrial morphology, a process regulated by mitochondrial dynamics whereby the joining of two mitochondria, fusion, inhibits apoptosis while fission, the division of a mitochondrion, initiates apoptosis. Mitochondrial morphology of A549 cells displayed an elongated phenotype-mimicking cells deficient in mitochondrial fission protein, Dynamin-related protein 1 (Drp1). A549 cells had impaired Drp1 mitochondrial recruitment and decreased Drp1-dependent fission. Cytochrome c release and caspase-3 and PARP cleavage were impaired both basally and with apoptotic stimuli in A549 cells. Increased mitochondrial mass was observed in A549 cells, suggesting defects in mitophagy (mitochondrial selective autophagy). A549 cells had decreased LC3-II lipidation and lysosomal inhibition suggesting defects in autophagy occur upstream of lysosomal degradation. Immunostaining indicated mitochondrial localized LC3 punctae in A549 cells increased after mitochondrial uncoupling or with a combination of mitochondrial depolarization and ectopic Drp1 expression. Increased inhibition of apoptosis in A549 cells is correlated with impeded mitochondrial fission and mitophagy. We suggest mitochondrial fission defects contribute to apoptotic resistance in A549 cells.
C1 [Thomas, Kelly Jean] Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA.
   [Thomas, Kelly Jean; Jacobson, Marty R.] St Marys Hosp, Saccomanno Res Inst, Grand Junction, CO USA.
   [Thomas, Kelly Jean; Jacobson, Marty R.] Reg Med Ctr, Grand Junction, CO USA.
RP Thomas, KJ (reprint author), Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA.
EM kjcraig@coloradomesa.edu
FU St. Mary's Hospital; Regional Medical Center, St. Mary's Hospital
   Foundation
FX Funding: St. Mary's Hospital and Regional Medical Center, St. Mary's
   Hospital Foundation. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2
   Autret A, 2010, CELL MOL LIFE SCI, V67, P1599, DOI 10.1007/s00018-010-0286-x
   Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792
   Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226
   Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509
   Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932
   Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devce1.2007.11.019
   Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200
   Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062
   Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137
   Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004
   Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058
   Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367
   Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035
   LEE HK, 1992, ARCH BIOCHEM BIOPHYS, V296, P271, DOI 10.1016/0003-9861(92)90572-E
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   LEHMAN TA, 1991, CANCER RES, V51, P4090
   Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Mopert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016
   MOMIKI S, 1991, INVAS METAST, V11, P66
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4
   Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   Ryang Dae-Yeul, 2007, Korean Journal of Internal Medicine, V22, P263, DOI 10.3904/kjim.2007.22.4.263
   Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701
   SATOH H, 1993, MOL CARCINOGEN, V7, P157, DOI 10.1002/mc.2940070306
   Schiller JH, 1998, IN VITRO CELL DEV-AN, V34, P283, DOI 10.1007/s11626-998-0004-2
   Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Tan ML, 2009, PHARM RES-DORDR, V26, P1547, DOI 10.1007/s11095-009-9895-1
   Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
   Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418
NR 51
TC 37
Z9 37
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 20
PY 2012
VL 7
IS 9
AR e45319
DI 10.1371/journal.pone.0045319
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 014PT
UT WOS:000309388900041
PM 23028930
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Kemeny, S
   Dery, D
   Loboda, Y
   Rovner, M
   Lev, T
   Zuri, D
   Finberg, JPM
   Larisch, S
AF Kemeny, Stav
   Dery, Dikla
   Loboda, Yelena
   Rovner, Marshall
   Lev, Tali
   Zuri, Dotan
   Finberg, John P. M.
   Larisch, Sarit
TI Parkin Promotes Degradation of the Mitochondrial Pro-Apoptotic ARTS
   Protein
SO PLOS ONE
LA English
DT Article
ID RECESSIVE JUVENILE PARKINSONISM; LEWY-BODY FORMATION; CELL-DEATH;
   ALPHA-SYNUCLEIN; NEURONAL DEATH; MOLECULAR PATHWAYS; BINDING PROTEIN;
   GROWTH-FACTOR; DISEASE; P53
AB Parkinson's disease (PD) is associated with excessive cell death causing selective loss of dopaminergic neurons. Dysfunction of the Ubiquitin Proteasome System (UPS) is associated with the pathophysiology of PD. Mutations in Parkin which impair its E3-ligase activity play a major role in the pathogenesis of inherited PD. ARTS (Sept4_i2) is a mitochondrial protein, which initiates caspase activation upstream of cytochrome c release in the mitochondrial apoptotic pathway. Here we show that Parkin serves as an E3-ubiquitin ligase to restrict the levels of ARTS through UPS-mediated degradation. Though Parkin binds equally to ARTS and Sept4_i1 (H5/PNUTL2), the non-apoptotic splice variant of Sept4, Parkin ubiquitinates and degrades only ARTS. Thus, the effect of Parkin on ARTS is specific and probably related to its pro-apoptotic function. High levels of ARTS are sufficient to promote apoptosis in cultured neuronal cells, and rat brains treated with 6-OHDA reveal high levels of ARTS. However, over-expression of Parkin can protect cells from ARTS-induced apoptosis. Furthermore, Parkin loss-of-function experiments reveal that reduction of Parkin causes increased levels of ARTS and apoptosis. We propose that in brain cells in which the E3-ligase activity of Parkin is compromised, ARTS levels increase and facilitate apoptosis. Thus, ARTS is a novel substrate of Parkin. These observations link Parkin directly to a pro-apoptotic protein and reveal a novel connection between Parkin, apoptosis, and PD.
C1 [Kemeny, Stav; Dery, Dikla; Rovner, Marshall; Lev, Tali; Zuri, Dotan; Larisch, Sarit] Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel.
   [Kemeny, Stav; Loboda, Yelena; Finberg, John P. M.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Mol Pharmacol, Haifa, Israel.
RP Kemeny, S (reprint author), Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel.
EM saritlarisch@gmail.com
OI Kemeny, Stav/0000-0002-5292-215X
FU Aubrey and Ella Brown Fellowship; Muriel Edith Rickman Trust (UK);
   Johnson Johnson
FX This work was supported by funds from "The Aubrey and Ella Brown
   Fellowship'' (supporting a stipend for Dr. Kemeny), The Muriel Edith
   Rickman Trust (UK) (supporting equipment purchase for Dr. Finberg) and
   Johnson & Johnson (Focused Giving Program COSAT grant to Dr. Larisch).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abraham MC, 2007, DEV CELL, V13, P464, DOI 10.1016/j.devcel.2007.09.008
   Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8
   Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X
   Bornstein B, 2011, APOPTOSIS       0623
   Bornstein B, 2012, INT J BIOCHEM CELL B, V44, P489, DOI 10.1016/j.biocel.2011.12.005
   Braak H, 1996, J NEURAL TRANSM-SUPP, P1
   Braak H, 1996, ACTA NEUROL SCAND, V93, P3
   Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293
   Carp MJ, 2008, SEPTINS, P281
   Chan NC, 2011, HUM MOL GENET
   Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596
   Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8
   Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144
   Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159
   da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798
   Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753
   Dawson TM, 2002, NATURE NEUROSCIENCE
   Dawson V L, 1995, Adv Pharmacol, V34, P323
   Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901
   Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514
   Edison N, 2012, CLIN CANC RES
   Edison N, 2011, CELL DEATH DIFFER
   Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725
   Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441
   Finberg JPM, 2010, RESTOR NEUROL NEUROS, V28, P803, DOI 10.3233/RNN-2010-0551
   Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07
   Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433
   Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064
   Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110
   Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002
   Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001
   Goetz CG, 2007, MOVEMENT DISORD, V22, P179, DOI 10.1002/mds.21226
   Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012
   Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155
   Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031
   Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654
   Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0
   Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200
   Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027
   Kitada T, 1998, NATURE, V392, P605
   Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0
   Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Kuroda Y, 2006, BIOCHEM BIOPH RES CO, V348, P787, DOI 10.1016/j.bbrc.2006.06.201
   Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924
   Larisch S, 2000, NAT CELL BIOL, V2, P915
   Larisch-Bloch S, 2000, CELL GROWTH DIFFER, V11, P1
   Lee TV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002261
   Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4
   Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130
   Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101
   Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1053/JNEUROSCI.4474-04.2005
   Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8
   Lotan R, 2005, J BIOL CHEM, V280, P25802, DOI 10.1074/jbc.M501955200
   Lu BW, 2004, MOL PSYCHIATR, V9, P6, DOI 10.1038/sj.mp.4001417
   Matsumine H, 2001, METH MOLEC MED, V62, P13, DOI 10.1385/1-59259-142-6:13
   McCarthy N, 2010, NAT REV CANCER, V10, P816, DOI 10.1038/nrc2969
   Morley JF, 2010, NEUROLOGY, V75, pS9, DOI 10.1212/WNL.0b013e3181fb3628
   Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585
   Mouatt-Prigent A, 2004, J NEURAL TRANSM, V111, P1209, DOI 10.1007/s00702-004-0144-9
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767
   Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675
   Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524
   PEREZPOLO JR, 1982, DEV NEUROSCI-BASEL, V5, P418, DOI 10.1159/000112702
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Prunell GF, 2004, J NEUROSCI RES, V78, P1, DOI 10.1002/jnr.20252
   Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118
   Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292
   Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178
   Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Shehadeh L, 2009, MOVEMENT DISORD, V24, P204, DOI 10.1002/mds.22306
   Shimura H, 2000, NAT GENET, V25, P302
   Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565
   Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001
   Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200
   Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4
   Turmel H, 2001, MOVEMENT DISORD, V16, P185, DOI 10.1002/mds.1037
   Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026
   Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009
   Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104
   Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774
   Xie H, 1999, CELL MOTIL CYTOSKEL, V43, P52, DOI 10.1002/(SICI)1097-0169(1999)43:1<52::AID-CM6>3.0.CO;2-5
   Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0
   Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012
   Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797
   Zieger B, 2000, GENE, V261, P197, DOI 10.1016/S0378-1119(00)00527-8
NR 93
TC 20
Z9 21
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2012
VL 7
IS 7
AR e38837
DI 10.1371/journal.pone.0038837
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973IV
UT WOS:000306354700005
PM 22792159
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Bian, MJ
   Liu, J
   Hong, XQ
   Yu, M
   Huang, YF
   Sheng, ZJ
   Fei, J
   Huang, F
AF Bian, Minjuan
   Liu, Jie
   Hong, Xiaoqi
   Yu, Mei
   Huang, Yufang
   Sheng, Zhejin
   Fei, Jian
   Huang, Fang
TI Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration
   Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
SO PLOS ONE
LA English
DT Article
ID ALPHA-SYNUCLEIN AGGREGATION; UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; RAT
   MODEL; MITOCHONDRIAL DYSFUNCTION; NEURONAL DEGENERATION; PINK1/PARKIN
   PATHWAY; OXIDATIVE DAMAGE; MOTOR DEFICITS; MOUSE MODEL
AB Mutations in the parkin gene are currently thought to be the most common cause of recessive familial Parkinsonism. Parkin functions as an E3 ligase to regulate protein turnover, and its function in mitochondrial quality control has been reported recently. Overexpression of parkin has been found to prevent neuronal degeneration under various conditions both in vivo and in vitro. Here, we generated a transgenic mouse model in which expression of wild type parkin was driven by neuron-specific enolase (NSE) promoter. We reported that both young and old parkin transgenic mice exhibited less reduction of striatal TH protein and number of TH positive neurons in the substantia nigra induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP), compared to wild type littermates. MPTP-induced mitochondrial impairment in the substantia nigra was improved in young parkin transgenic mice. Decreased striatal alpha-synuclein was demonstrated in old parkin transgenic mice. These results provide reliable evidence from the transgenic mouse model for parkin that overexpression of parkin may attenuate dopaminergic neurodegeneration induced by MPTP through protection of mitochondria and reduction of alpha-synuclein in the nigrostriatal pathway.
C1 [Bian, Minjuan; Liu, Jie; Hong, Xiaoqi; Yu, Mei; Huang, Yufang; Huang, Fang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.
   [Sheng, Zhejin; Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.
   [Huang, Fang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.
RP Bian, MJ (reprint author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.
EM huangf@shmu.edu.cn
FU National Natural Science Foundation of China [90919004, 81171188];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20110071110039]; Ministry of Science and Technology of China
   [2012CB966300, 2010CB945501, 2011CB965103]
FX This work was supported by National Natural Science Foundation of China
   (90919004, 81171188); Specialized Research Fund for the Doctoral Program
   of Higher Education (20110071110039) and grants from the Ministry of
   Science and Technology of China (2012CB966300, 2010CB945501,
   2011CB965103). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nm1434
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Beal MF, 2003, ANN NY ACAD SCI, V991, P120
   Beere HM, 2000, NAT CELL BIOL, V2, P469
   Bian MJ, 2008, ACTA BIOCH BIOPH SIN, V40, P505, DOI 10.1111/j.1745-7270.2008.00423.x
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83
   Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101
   Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8
   Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021
   Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753
   Duvoisin R C, 1999, Adv Neurol, V80, P161
   Dzaman-Serafin Sylwia, 2005, Pol Merkur Lekarski, V19, P215
   Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495
   FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3
   Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308
   Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gibrat C, 2009, J NEUROCHEM, V109, P1469, DOI 10.1111/j.1471-4159.2009.06072.x
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007
   Hu JH, 2003, J NEUROSCI RES, V74, P614, DOI 10.1002/jnr.10780
   Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3
   Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Kitada T, 1998, NATURE, V392, P605
   Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200
   Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200
   Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2712-05.2005
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Le Couteur David G, 2002, Rev Environ Health, V17, P51
   Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652
   Liberatore GT, 1999, NAT MED, V5, P1403
   Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101
   Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009
   Manfredsson FP, 2007, EXP NEUROL, V207, P289, DOI 10.1016/j.expneurol.2007.06.019
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021
   Mizuno Y, 1999, Adv Neurol, V80, P171
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789
   Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/mt.sj.6300067
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
   Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839
   Shimura H, 2000, NAT GENET, V25, P302
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van Noort JM, 2008, J PATHOL, V214, P267, DOI 10.1002/path.2273
   Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Xuan Q, 2011, J NEURAL TRANSM, V118, P1575, DOI 10.1007/s00702-011-0636-3
   Yang LC, 1998, J NEUROSCI, V18, P8145
   Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd
   Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338
   Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248
   Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/01.WCB.000014701.97890.3B
   Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004
   Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797
NR 80
TC 31
Z9 32
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2012
VL 7
IS 6
AR e39953
DI 10.1371/journal.pone.0039953
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 967FO
UT WOS:000305892100151
PM 22792139
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Abramov, AY
   Gegg, M
   Grunewald, A
   Wood, NW
   Klein, C
   Schapira, AHV
AF Abramov, Andrey Yurevich
   Gegg, Matthew
   Grunewald, Anne
   Wood, Nicholas William
   Klein, Christine
   Schapira, Anthony Henry Vernon
TI Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; PINK1/PARKIN PATHWAY; OXIDATIVE STRESS;
   NEURODEGENERATION; MITOPHAGY; MORPHOLOGY; MITOFUSIN; DEFECTS; CALCIUM;
   DNA
AB Background: Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to determine whether cells derived from PD patients with a range of PINK1 mutations demonstrate similar defects of mitochondrial function, whether the nature and severity of the abnormalities vary between mutations and correlate with clinical features.
   Methodology: We investigated mitochondrial bioenergetics in live fibroblasts from PINK1 mutation patients using single cell techniques. We found that fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening. There was an increase in the basal rate of free radical production in the mutant cells. The pattern and severity of abnormality varied between different mutations, and the less severe defects in these cells were associated with later age of onset of PD.
   Conclusions: The results provide insight into the molecular pathology of PINK1 mutations in PD and also confirm the critical role of substrate availability in determining the biochemical phenotype - thereby offering the potential for novel therapeutic strategies to circumvent these abnormalities.
C1 [Abramov, Andrey Yurevich; Wood, Nicholas William] UCL Inst Neurol, Dept Mol Neurosci, London, England.
   [Gegg, Matthew; Schapira, Anthony Henry Vernon] UCL Inst Neurol, Dept Clin Neurosci, London, England.
   [Grunewald, Anne; Klein, Christine] Univ Lubeck, Dept Neurol, Lubeck, Germany.
RP Abramov, AY (reprint author), UCL Inst Neurol, Dept Mol Neurosci, London, England.
EM a.abramov@ucl.ac.uk; a.schapira@ucl.ac.uk
RI Abramov, Andrey/H-9053-2012; Schapira, Anthony/A-1245-2010; Gegg,
   Matthew/B-4826-2011; Wood, Nicholas W/C-2505-2009
OI Abramov, Andrey/0000-0002-7646-7235; Schapira,
   Anthony/0000-0002-3018-3966; Gegg, Matthew/0000-0001-8093-0723; Wood,
   Nicholas W/0000-0002-9500-3348
FU Wellcome Trust/MRC [WT089698]; Kattan Trust; Medical Research Council
   [MC_G1000735]; Parkinson's UK [K-0803, G-0612, F-0806]
FX This work was supported in part by the Wellcome Trust/MRC Joint Call in
   Neurodegeneration award (WT089698) to the UK Parkinson's Disease
   Consortium (UKPDC), and by Kattan Trust. Dr. Abramov is a Parkinson's UK
   Senior Research Fellow. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. No additional external funding was received for this study.
CR Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833
   Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52
   Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com
   Tan EK, 2006, MOVEMENT DISORD, V21, P789, DOI 10.1002/mds.20810
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 29
TC 60
Z9 60
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2011
VL 6
IS 10
AR e25622
DI 10.1371/journal.pone.0025622
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834SM
UT WOS:000295984400015
PM 22043288
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Tang, F
   Wang, B
   Li, N
   Wu, YF
   Jia, JY
   Suo, TL
   Chen, Q
   Liu, YJ
   Tang, J
AF Tang, Fei
   Wang, Bin
   Li, Na
   Wu, Yanfang
   Jia, Junying
   Suo, Talin
   Chen, Quan
   Liu, Yong-Jun
   Tang, Jie
TI RNF185, a Novel Mitochondrial Ubiquitin E3 Ligase, Regulates Autophagy
   through Interaction with BNIP1
SO PLOS ONE
LA English
DT Article
ID BCL-2 FAMILY-MEMBERS; CELL-DEATH; SELECTIVE AUTOPHAGY; FLUORESCENT
   PROTEIN; QUALITY-CONTROL; MITOPHAGY; APOPTOSIS; DEGRADATION; MECHANISMS;
   BECLIN-1
AB Autophagy is an evolutionarily conserved catabolic process that allows recycling of cytoplasmic organelles, such as mitochondria, to offer a bioenergetically efficient pathway for cell survival. Considerable progress has been made in characterizing mitochondrial autophagy. However, the dedicated ubiquitin E3 ligases targeting mitochondria for autophagy have not been revealed. Here we show that human RNF185 is a mitochondrial ubiquitin E3 ligase that regulates selective mitochondrial autophagy in cultured cells. The two C-terminal transmembrane domains of human RNF185 mediate its localization to mitochondrial outer membrane. RNF185 stimulates LC3II accumulation and the formation of autophagolysosomes in human cell lines. We further identified the Bcl-2 family protein BNIP1 as one of the substrates for RNF185. Human BNIP1 colocalizes with RNF185 at mitochondria and is polyubiquitinated by RNF185 through K63-based ubiquitin linkage in vivo. The polyubiquitinated BNIP1 is capable of recruiting autophagy receptor p62, which simultaneously binds both ubiquitin and LC3 to link ubiquitination and autophagy. Our study might reveal a novel RNF185-mediated mechanism for modulating mitochondrial homeostasis through autophagy.
C1 [Tang, Fei; Li, Na; Wu, Yanfang; Jia, Junying; Suo, Talin; Tang, Jie] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.
   [Wang, Bin; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100080, Peoples R China.
   [Tang, Fei; Wang, Bin; Suo, Talin] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China.
   [Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.
   [Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA.
RP Tang, F (reprint author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.
EM jtang@ibp.ac.cn
RI Tang, Fei/L-6750-2016
OI Tang, Fei/0000-0003-1475-5028; Chen, Quan/0000-0001-7539-8728
FU Ministry of Science and Technololgy of China [2006CB504304]; Ministry of
   Health of China [008ZX10002-008]
FX This work was supported by grants from Ministry of Science and
   Technololgy of China (2006CB504304) and Ministry of Health of China
   (008ZX10002-008). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09
   BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X
   Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012
   Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045
   Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311
   Elmore SP, 2001, FASEB J, V15, P2286
   Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713
   Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200
   Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5
   Furukawa Manabu, 2005, V301, P37
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Germain M, 2010, CLIN SCI, V118, P173, DOI 10.1042/CS20090310
   Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425
   Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kanki T, 2010, AUTOPHAGY, V6, P433, DOI 10.4161/auto.6.3.11420
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064
   KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780
   Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260
   Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487
   Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689
   Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237
   Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657
   McEwan DG, 2010, CELL, V141, P564, DOI 10.1016/j.cell.2010.04.030
   Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011
   Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023
   Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333
   Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012
   Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019
   Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503
   Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783
   RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X
   Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422
   Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192
   Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634
   Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444
   Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3
   Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681
   Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009
   Wrighton KH, 2010, NAT REV MOL CELL BIO, V11, P464, DOI [10.1038/nrm2920, 10.1038/nrm2930]
   Yasuda M, 2000, ONCOGENE, V19, P2363, DOI 10.1038/sj.onc.1203565
   Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023
   Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482
   Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902
   Zhang H, 1999, FEBS LETT, V448, P23, DOI 10.1016/S0014-5793(99)00335-X
   Zhang HM, 2003, APOPTOSIS, V8, P229, DOI 10.1023/A:1023616620970
   Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16
NR 78
TC 10
Z9 13
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2011
VL 6
IS 9
AR e24367
DI 10.1371/journal.pone.0024367
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 819CN
UT WOS:000294803100023
PM 21931693
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Huang, CQ
   Andres, AM
   Ratliff, EP
   Hernandez, G
   Lee, P
   Gottlieb, RA
AF Huang, Chengqun
   Andres, Allen M.
   Ratliff, Eric P.
   Hernandez, Genaro
   Lee, Pamela
   Gottlieb, Roberta A.
TI Preconditioning Involves Selective Mitophagy Mediated by Parkin and
   p62/SQSTM1
SO PLOS ONE
LA English
DT Article
ID AUTOPHAGY; MITOCHONDRIA; DISEASE; DEGRADATION; PINK1; PROTECTION;
   INDUCTION; MITOFUSIN; PROTEINS; INJURY
AB Autophagy-dependent mitochondrial turnover in response to cellular stress is necessary for maintaining cellular homeostasis. However, the mechanisms that govern the selective targeting of damaged mitochondria are poorly understood. Parkin, an E3 ubiquitin ligase, has been shown to be essential for the selective clearance of damaged mitochondria. Parkin is expressed in the heart, yet its function has not been investigated in the context of cardioprotection. We previously reported that autophagy is required for cardioprotection by ischemic preconditioning (IPC). In the present study, we used simulated ischemia (sI) in vitro and IPC of hearts to investigate the role of Parkin in mediating cardioprotection ex vivo and in vivo. In HL-1 cells, sI induced Parkin translocation to mitochondria and mitochondrial elimination. IPC induced Parkin translocation to mitochondria in Langendorff-perfused rat hearts and in vivo in mice subjected to regional IPC. Mitochondrial depolarization with an uncoupling agent similarly induced Parkin translocation to mitochondria in cells and Langendorff-perfused rat hearts. Mitochondrial loss was blunted in Atg5-deficient cells, revealing the requirement for autophagy in mitochondrial elimination. Consistent with previous reports indicating a role for p62/SQSTM1 in mitophagy, we found that depletion of p62 attenuated mitophagy and exacerbated cell death in HL-1 cardiomyocytes subjected to sI. While wild type mice showed p62 translocation to mitochondria and an increase in ubiquitination, Parkin knockout mice exhibited attenuated IPC-induced p62 translocation to the mitochondria. Importantly, ablation of Parkin in mice abolished the cardioprotective effects of IPC. These results reveal for the first time the crucial role of Parkin and mitophagy in cardioprotection.
C1 [Huang, Chengqun; Andres, Allen M.; Ratliff, Eric P.; Hernandez, Genaro; Lee, Pamela; Gottlieb, Roberta A.] San Diego State Univ, BioSci Ctr, San Diego, CA 92182 USA.
RP Huang, CQ (reprint author), San Diego State Univ, BioSci Ctr, San Diego, CA 92182 USA.
EM robbieg@sciences.sdsu.edu
OI Gottlieb, Roberta/0000-0002-1432-006X
FU NIH [5R01HL060590-14, 5R01AG033283-04]; SDSU MBRS/IMSD
   [2R25GM058906-09A2];  [3R01AG033283-02S1]
FX This work was supported by NIH 5R01HL060590-14 and 5R01AG033283-04 to
   RAG. AA is supported by 3R01AG033283-02S1 and GH is supported by SDSU
   MBRS/IMSD Program 2R25GM058906-09A2. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019
   Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0
   CARREIRA RS, 2010, AUTOPHAGY, V6
   CHAN NC, HUM MOL GENET, V20, P1726
   DECKER RS, 1980, AM J PATHOL, V98, P425
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010
   Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100
   Elmore SP, 2001, FASEB J, V15, P2286
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   GOTTLIEB RA, 2010, BIOCH BIOPH IN PRESS
   Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200
   Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x
   HUANG C, 2009, AM J PHYSL HEART CIR
   Huang C, 2010, J CARDIOVASC TRANSL
   HUANG C, J CARDIOVASCULAR TRA, V3, P365
   Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3
   Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221
   KIM I, AM J PHYSL CELL PHYS
   KIM I, ANTIOXID REDOX SIGNA
   Kitada T, 1998, NATURE, V392, P605
   Kitada T, 2000, MAMM GENOME, V11, P417, DOI 10.1007/s003350010080
   Korge P, 2002, P NATL ACAD SCI USA, V99, P3312, DOI 10.1073/pnas.052713199
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004
   Sybers H D, 1976, Recent Adv Stud Cardiac Struct Metab, V12, P453
   Vives-Bauza C, 2010, AUTOPHAGY, V6, P315, DOI 10.4161/auto.6.2.11199
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   VIVESBAUZA C, 2009, P NATL ACAD SCI USA, V107, P378
   Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250
   Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008
   Zesiewicz TA, 2004, PARKINSONISM RELAT D, V10, P417, DOI 10.1016/j.parkreldis.2004.04.001
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 46
TC 197
Z9 205
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2011
VL 6
IS 6
AR e20975
DI 10.1371/journal.pone.0020975
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 777JJ
UT WOS:000291611500055
PM 21687634
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Rakovic, A
   Grunewald, A
   Kottwitz, J
   Bruggemann, N
   Pramstaller, PP
   Lohmann, K
   Klein, C
AF Rakovic, Aleksandar
   Gruenewald, Anne
   Kottwitz, Jan
   Brueggemann, Norbert
   Pramstaller, Peter P.
   Lohmann, Katja
   Klein, Christine
TI Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in
   Human Fibroblasts
SO PLOS ONE
LA English
DT Article
ID COMPLEX I DEFICIENCY; MITOCHONDRIAL-FUNCTION; DISEASE; DROSOPHILA;
   MITOPHAGY; DEGRADATION; MORPHOLOGY; FUSION; PROTEASOME; MUTANTS
AB PINK1 and Parkin mutations cause recessive Parkinson's disease (PD). In Drosophila and SH-SY5Y cells, Parkin is recruited by PINK1 to damaged mitochondria, where it ubiquitinates Mitofusins and consequently promotes mitochondrial fission and mitophagy. Here, we investigated the impact of mutations in endogenous PINK1 and Parkin on the ubiquitination of mitochondrial fusion and fission factors and the mitochondrial network structure. Treating control fibroblasts with mitochondrial membrane potential (Delta psi) inhibitors or H(2)O(2) resulted in ubiquitination of Mfn1/2 but not of OPA1 or Fis1. Ubiquitination of Mitofusins through the PINK1/Parkin pathway was observed within 1 h of treatment. Upon combined inhibition of Delta psi and the ubiquitin proteasome system (UPS), no ubiquitination of Mitofusins was detected. Regarding morphological changes, we observed a trend towards increased mitochondrial branching in PD patient cells upon mitochondrial stress. For the first time in PD patient-derived cells, we demonstrate that mutations in PINK1 and Parkin impair ubiquitination of Mitofusins. In the presence of UPS inhibitors, ubiquitinated Mitofusin is deubiquitinated by the UPS but not degraded, suggesting that the UPS is involved in Mitofusin degradation.
C1 [Rakovic, Aleksandar; Gruenewald, Anne; Kottwitz, Jan; Brueggemann, Norbert; Lohmann, Katja; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.
   [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy.
RP Rakovic, A (reprint author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.
EM christine.klein@neuro.uni-luebeck.de
RI Pramstaller, Peter/C-2357-2008
OI Kottwitz, Jan/0000-0002-2993-4312
FU Medical Faculty of the University of Lubeck; Volkswagen Foundation;
   Hermann and Lilly Schilling Foundation; German Research Foundation (DFG)
   [GR 3731/1-1]; Hilde Ulrichs Foundation for Parkinson's Disease
   Research; EU [EU-LSHB-CT-2006-037544]; German 'Bundesministerium fur
   Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3]
FX This work was supported by the Medical Faculty of the University of
   Lubeck [to A. G.], the Volkswagen Foundation [to C. K.], the Hermann and
   Lilly Schilling Foundation [to C. K.], the German Research Foundation
   (DFG) [GR 3731/1-1 to A. G.], the Hilde Ulrichs Foundation for
   Parkinson's Disease Research [to C. K.], the EU Grant GENEPARK
   [EU-LSHB-CT-2006-037544 to C. K.], and the German 'Bundesministerium fur
   Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3 to C. K.]. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756
   GEGG ME, 2010, HUM MOL GENET
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Grunewald A, 2007, NEUROGENETICS, V8, P103, DOI 10.1007/s10048-006-0072-y
   Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833
   Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103
   Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016
   Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LUTZ AK, 2009, J BIOL CHEM
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Moro E, 2008, NEUROLOGY, V70, P1186, DOI 10.1212/01.wnl.0000307748.11216.03
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587
   Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Verma R, 2005, METHOD ENZYMOL, V398, P391, DOI 10.1016/S0076-6879(05)98032-4
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 44
TC 113
Z9 118
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 8
PY 2011
VL 6
IS 3
AR e16746
DI 10.1371/journal.pone.0016746
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 732FI
UT WOS:000288170000007
PM 21408142
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Akundi, RS
   Huang, ZY
   Eason, J
   Pandya, JD
   Zhi, LT
   Cass, WA
   Sullivan, PG
   Bueler, H
AF Akundi, Ravi S.
   Huang, Zhenyu
   Eason, Joshua
   Pandya, Jignesh D.
   Zhi, Lianteng
   Cass, Wayne A.
   Sullivan, Patrick G.
   Bueeler, Hansruedi
TI Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of
   Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient
   Mice
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GLYCOGEN-SYNTHASE KINASE-3-BETA;
   ACTIVATING TRANSCRIPTION FACTOR-3; NEURONS FOLLOWING AXOTOMY;
   EARLY-ONSET PARKINSONISM; C-JUN PHOSPHORYLATION; GROWTH-FACTOR-ALPHA;
   FOS MESSENGER-RNA; OXIDATIVE STRESS
AB Background: PTEN-induced kinase 1 (PINK1) is linked to recessive Parkinsonism (EOPD). Pink1 deletion results in impaired dopamine (DA) release and decreased mitochondrial respiration in the striatum of mice. To reveal additional mechanisms of Pink1-related dopaminergic dysfunction, we studied Ca(2+) vulnerability of purified brain mitochondria, DA levels and metabolism and whether signaling pathways implicated in Parkinson's disease (PD) display altered activity in the nigrostriatal system of Pink1(-/-) mice.
   Methods and Findings: Purified brain mitochondria of Pink1(-/-) mice showed impaired Ca(2+) storage capacity, resulting in increased Ca(2+) induced mitochondrial permeability transition (mPT) that was rescued by cyclosporine A. A subpopulation of neurons in the substantia nigra of Pink1(-/-) mice accumulated phospho-c-Jun, showing that Jun N-terminal kinase (JNK) activity is increased. Pink1(-/-) mice 6 months and older displayed reduced DA levels associated with increased DA turnover. Moreover, Pink1(-/-) mice had increased levels of IL-1 beta, IL-12 and IL-10 in the striatum after peripheral challenge with lipopolysaccharide (LPS), and Pink1(-/-) embryonic fibroblasts showed decreased basal and inflammatory cytokine-induced nuclear factor kappa-beta (NF-kappa B) activity. Quantitative transcriptional profiling in the striatum revealed that Pink1(-/-) mice differentially express genes that (i) are upregulated in animals with experimentally induced dopaminergic lesions, (ii) regulate innate immune responses and/or apoptosis and (iii) promote axonal regeneration and sprouting.
   Conclusions: Increased mitochondrial Ca(2+) sensitivity and JNK activity are early defects in Pink1(-/-) mice that precede reduced DA levels and abnormal DA homeostasis and may contribute to neuronal dysfunction in familial PD. Differential gene expression in the nigrostriatal system of Pink1(-/-) mice supports early dopaminergic dysfunction and shows that Pink1 deletion causes aberrant expression of genes that regulate innate immune responses. While some differentially expressed genes may mitigate neurodegeneration, increased LPS-induced brain cytokine expression and impaired cytokine-induced NF-kappa B activation may predispose neurons of Pink1(-/-) mice to inflammation and injury-induced cell death.
C1 [Akundi, Ravi S.; Huang, Zhenyu; Eason, Joshua; Pandya, Jignesh D.; Zhi, Lianteng; Cass, Wayne A.; Sullivan, Patrick G.; Bueeler, Hansruedi] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.
   [Sullivan, Patrick G.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.
RP Akundi, RS (reprint author), Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.
EM hansruedi.bueler@uky.edu
RI Bueler, Hansruedi/J-6965-2017; Akundi, Ravi Shankar/J-2673-2019
OI Bueler, Hansruedi/0000-0002-4892-7177; Akundi, Ravi
   Shankar/0000-0003-3782-5965
FU National Center for Research Resources (NCRR) [P20 RR15592]; Parkinson
   Schweiz; American Parkinson's Disease Association (APDA)
FX This work was supported in part by a COBRE grant (P20 RR15592) from the
   National Center for Research Resources (NCRR), as well as by grants from
   Parkinson Schweiz and the American Parkinson's Disease Association
   (APDA) to H.B. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198
   Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738
   Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200
   Badiani A, 1998, J NEUROSCI, V18, P10579
   Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083
   BEUREL E, TRENDS IMMUNOL, V31, P24
   Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82
   Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x
   Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040
   Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200
   Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0
   Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002
   Cadet P, 2003, INT J MOL MED, V12, P485
   Campbell G, 2005, EXP NEUROL, V192, P340, DOI 10.1016/j.expneurol.2004.11.026
   Cao JP, 2008, BRAIN RES BULL, V76, P505, DOI 10.1016/j.brainresbull.2008.03.007
   Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6
   Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chen BPC, 1996, MOL CELL BIOL, V16, P1157
   Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje
   Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030
   CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7
   CHERRA SJ, 2009, AUTOPHAGY, V5
   Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103
   Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131
   Desteno DA, 2009, NEUROSCIENCE, V162, P118, DOI 10.1016/j.neuroscience.2009.04.052
   Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008
   Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007
   Doucet JP, 1996, EUR J NEUROSCI, V8, P365, DOI 10.1111/j.1460-9568.1996.tb01220.x
   DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S
   DRAGUNOW M, 1991, MOL BRAIN RES, V10, P355, DOI 10.1016/0169-328X(91)90096-G
   Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410
   Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015
   Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900
   Francis JS, 2004, MOL BRAIN RES, V124, P199, DOI 10.1016/j.molbrainres.2003.10.027
   Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008
   Fridmacher V, 2003, J NEUROSCI, V23, P9403
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Garcia-Gorostiaga I., 2009, ANN NEUROL, V65, P761
   Garcia-Gorostiaga I, 2009, ANN NEUROL, V65, P759, DOI 10.1002/ana.21687
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gayle DA, 2002, DEV BRAIN RES, V133, P27, DOI 10.1016/S0165-3806(01)00315-7
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927
   Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104
   Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768
   Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785
   Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753
   HARDING AJ, 1994, J NEUROSCI METH, V51, P83, DOI 10.1016/0165-0270(94)90028-0
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101
   JOH TH, 1993, ADV NEUROL, V60, P316
   Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113
   Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x
   Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200
   Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200
   Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104
   Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104
   Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008
   Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497
   Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77
   Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3
   Liang YD, 2009, BRAIN RES, V1286, P221, DOI 10.1016/j.brainres.2009.06.049
   Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4
   Liu M, 2010, J NEUROCHEM, V112, P773, DOI 10.1111/j.1471-4159.2009.06497.x
   Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035
   Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081
   Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200
   Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221
   Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168
   Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001
   Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3
   Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837
   McCoy MK, 2008, MOL THER, V16, P1572, DOI 10.1038/mt.2008.146
   Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106
   Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x
   Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3
   MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8
   MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3
   Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003
   Nagao M, 2009, NEUROSCI LETT, V449, P103, DOI 10.1016/j.neulet.2008.10.104
   Nakagomi S, 2003, J NEUROSCI, V23, P5187
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nilsson A, 2005, NEUROREPORT, V16, P213, DOI 10.1097/00001756-200502280-00002
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/mt.sj.6300067
   Pearson AG, 2003, MOL BRAIN RES, V120, P38, DOI 10.1016/j.molbrainres.2003.09.014
   POOLE AC, 2008, P NATL ACAD SCI US
   Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x
   Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565
   ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K
   Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88
   Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899
   Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007
   Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501
   Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114
   Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377
   Song DY, 2008, EXP NEUROL, V209, P268, DOI 10.1016/j.expneurol.2007.09.033
   Sossi V, 2002, J CEREBR BLOOD F MET, V22, P232, DOI 10.1097/00004647-200202000-00011
   SPINA MB, 1989, P NATL ACAD SCI USA, V86, P1398, DOI 10.1073/pnas.86.4.1398
   Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje.
   Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com
   Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005
   Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130
   SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091
   Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6
   Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415
   Svenningsson P, 2000, NEUROSCIENCE, V99, P457, DOI 10.1016/S0306-4522(00)00213-X
   Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200
   Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531
   Tang WH, 2009, CELL RES, V19, P758, DOI 10.1038/cr.2009.57
   Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004
   Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004
   Teismann P, 2001, NEUROREPORT, V12, P1049, DOI 10.1097/00001756-200104170-00037
   Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055
   Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8
   Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200
   VIVESBAUZA C, 2009, P NATL ACAD SCI US
   Vlug AS, 2005, EUR J NEUROSCI, V22, P1881, DOI 10.1111/j.1460-9568.2005.04389.x
   Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200
   Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334
   WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411
   Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622
   Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714
   Winter C, 1998, BRAIN RES, V801, P198, DOI 10.1016/S0006-8993(98)00601-5
   Winter C, 2002, MOL BRAIN RES, V104, P194, DOI 10.1016/S0169-328X(02)00378-9
   Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455
   Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002
   Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 144
TC 86
Z9 93
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 13
PY 2011
VL 6
IS 1
AR e16038
DI 10.1371/journal.pone.0016038
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 710ME
UT WOS:000286515000011
PM 21249202
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Grunewald, A
   Voges, L
   Rakovic, A
   Kasten, M
   Vandebona, H
   Hemmelmann, C
   Lohmann, K
   Orolicki, S
   Ramirez, A
   Schapira, AHV
   Pramstaller, PP
   Sue, CM
   Klein, C
AF Gruenewald, Anne
   Voges, Lisa
   Rakovic, Aleksandar
   Kasten, Meike
   Vandebona, Himesha
   Hemmelmann, Claudia
   Lohmann, Katja
   Orolicki, Slobodanka
   Ramirez, Alfredo
   Schapira, Anthony H. V.
   Pramstaller, Peter P.
   Sue, Carolyn M.
   Klein, Christine
TI Mutant Parkin Impairs Mitochondrial Function and Morphology in Human
   Fibroblasts
SO PLOS ONE
LA English
DT Article
ID COMPLEX I DEFICIENCY; DISEASE; PINK1; DROSOPHILA; MUTATIONS; MITOPHAGY;
   MICE; PATHOGENESIS; DYSFUNCTION; PATHOLOGY
AB Background: Mutations in Parkin are the most common cause of autosomal recessive Parkinson disease (PD). The mitochondrially localized E3 ubiquitin-protein ligase Parkin has been reported to be involved in respiratory chain function and mitochondrial dynamics. More recent publications also described a link between Parkin and mitophagy.
   Methodology/Principal Findings: In this study, we investigated the impact of Parkin mutations on mitochondrial function and morphology in a human cellular model. Fibroblasts were obtained from three members of an Italian PD family with two mutations in Parkin (homozygous c.1072delT, homozygous delEx7, compound-heterozygous c.1072delT/delEx7), as well as from two relatives without mutations. Furthermore, three unrelated compound-heterozygous patients (delEx3-4/duplEx7-12, delEx4/c.924C>T and delEx1/c.924C>T) and three unrelated age-matched controls were included. Fibroblasts were cultured under basal or paraquat-induced oxidative stress conditions. ATP synthesis rates and cellular levels were detected luminometrically. Activities of complexes I-IV and citrate synthase were measured spectrophotometrically in mitochondrial preparations or cell lysates. The mitochondrial membrane potential was measured with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide. Oxidative stress levels were investigated with the OxyBlot technique. The mitochondrial network was investigated immunocytochemically and the degree of branching was determined with image processing methods. We observed a decrease in the production and overall concentration of ATP coinciding with increased mitochondrial mass in Parkin-mutant fibroblasts. After an oxidative insult, the membrane potential decreased in patient cells but not in controls. We further determined higher levels of oxidized proteins in the mutants both under basal and stress conditions. The degree of mitochondrial network branching was comparable in mutants and controls under basal conditions and decreased to a similar extent under paraquat-induced stress.
   Conclusions: Our results indicate that Parkin mutations cause abnormal mitochondrial function and morphology in non-neuronal human cells.
C1 [Gruenewald, Anne; Voges, Lisa; Rakovic, Aleksandar; Kasten, Meike; Lohmann, Katja; Orolicki, Slobodanka; Ramirez, Alfredo; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.
   [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia.
   [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia.
   [Hemmelmann, Claudia] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany.
   [Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London, England.
   [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy.
RP Grunewald, A (reprint author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.
EM christine.klein@neuro.uni-luebeck.de
RI Ramirez, Alfredo/S-5126-2019; Pramstaller, Peter/C-2357-2008; Schapira,
   Anthony/A-1245-2010
OI Ramirez, Alfredo/0000-0003-4991-763X; Schapira,
   Anthony/0000-0002-3018-3966
FU German Research Foundation [GR 3731/1-1]; Fritz Thyssen Foundation;
   Boehringer Ingelheim Foundation; German Academic Exchange Service; EU
   [EU-LSHB-CT-2006-037544]; Deutsches Bundesministerium fur Bildung und
   Forschung [PNP-01GS08135-3]; Volkswagen Foundation; Hermann and Lilly
   Schilling Foundation; Hilde Ulrichs Foundation for Parkinson Disease
   Research; Australian Brain Foundation; University of Lubeck; Kattan
   Trust; Medical Research Council [G0601943]
FX This work was supported by grants from the German Research Foundation
   (GR 3731/1-1), the Fritz Thyssen Foundation, the Boehringer Ingelheim
   Foundation, the German Academic Exchange Service, the EU Grant GENEPARK
   (EU-LSHB-CT-2006-037544), the Deutsches Bundesministerium fur Bildung
   und Forschung (Nationales Genomforschungsnetz plus, PNP-01GS08135-3),
   the Volkswagen Foundation, the Hermann and Lilly Schilling Foundation,
   the Hilde Ulrichs Foundation for Parkinson Disease Research, the
   Australian Brain Foundation and the Medical Faculty of the University of
   Lubeck. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; Dr.
   Schapira is a board member of the Royal Free Hospital trust, served as a
   consultant for BI, GSK, Teva-Lundbeck, Orion-Novartis and EMD Serono,
   and received research support from the Kattan Trust. This does not alter
   the authors' adherence to all the PLoS ONE policies on sharing data and
   materials.
CR Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Esposti Mauro Degli, 2001, V65, P75
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200
   Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239
   Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104
   Ziviani E, 2010, AUTOPHAGY, V6
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 32
TC 83
Z9 86
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 27
PY 2010
VL 5
IS 9
AR e12962
DI 10.1371/journal.pone.0012962
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 654KL
UT WOS:000282167100003
PM 20885945
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Poole, AC
   Thomas, RE
   Yu, S
   Vincow, ES
   Pallanck, L
AF Poole, Angela C.
   Thomas, Ruth E.
   Yu, Selina
   Vincow, Evelyn S.
   Pallanck, Leo
TI The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of
   the PINK1/Parkin Pathway
SO PLOS ONE
LA English
DT Article
ID DROSOPHILA-PARKIN MUTANTS; SUBSTANTIA-NIGRA NEURONS; OXIDATIVE STRESS;
   DNA DELETIONS; DISEASE; PINK1; EXPRESSION; DYSFUNCTION; PATHOLOGY;
   FISSION
AB Loss-of-function mutations in the PINK1 or parkin genes result in recessive heritable forms of parkinsonism. Genetic studies of Drosophila orthologs of PINK1 and parkin indicate that PINK1, a mitochondrially targeted serine/threonine kinase, acts upstream of Parkin, a cytosolic ubiquitin-protein ligase, to promote mitochondrial fragmentation, although the molecular mechanisms by which the PINK1/Parkin pathway promotes mitochondrial fragmentation are unknown. We tested the hypothesis that PINK1 and Parkin promote mitochondrial fragmentation by targeting core components of the mitochondrial morphogenesis machinery for ubiquitination. We report that the steady-state abundance of the mitochondrial fusion-promoting factor Mitofusin (dMfn) is inversely correlated with the activity of PINK1 and Parkin in Drosophila. We further report that dMfn is ubiquitinated in a PINK1- and Parkin-dependent fashion and that dMfn co-immunoprecipitates with Parkin. By contrast, perturbations of PINK1 or Parkin did not influence the steady-state abundance of the mitochondrial fission-promoting factor Drp1 or the mitochondrial fusion-promoting factor Opa1, or the subcellular distribution of Drp1. Our findings suggest that dMfn is a direct substrate of the PINK1/Parkin pathway and that the mitochondrial morphological alterations and tissue degeneration phenotypes that derive from mutations in PINK1 and parkin result at least in part from reduced ubiquitin-mediated turnover of dMfn.
C1 [Poole, Angela C.; Thomas, Ruth E.; Yu, Selina; Vincow, Evelyn S.; Pallanck, Leo] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Vincow, Evelyn S.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98195 USA.
RP Poole, AC (reprint author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
EM pallanck@u.washington.edu
OI Poole, Angela/0000-0003-0278-7655
FU Genetic Approaches to Aging [5T32AG000057-32]; National Institutes of
   Health [1R01GM086394-01]
FX This work was supported by a Genetic Approaches to Aging Training Grant
   (5T32AG000057-32) to A. C. P. and a National Institutes of Health Grant
   (1R01GM086394-01) to L. P. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   BRAND M, 1993, DEVELOPMENT, V119, P1
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0
   Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x
   Hwa JJ, 2002, MECH DEVELOP, V116, P213, DOI 10.1016/S0925-4773(02)00141-7
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178
   Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987
   Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701
   Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   Sherer TB, 2002, NEUROSCIENTIST, V8, P192
   Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018
   Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94
   VIVESBAUZA C, 2009, P NATL ACAD SCI US
   Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102
   YANG Y, 2008, P NATL ACAD SCI US
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105
   ZIVIANI E, 2010, P NATL ACAD SCI US
NR 39
TC 273
Z9 275
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2010
VL 5
IS 3
AR e10054
DI 10.1371/journal.pone.0010054
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 580MX
UT WOS:000276454000014
PM 20383334
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

EF